unknown by unknown
is this: Will the same extensive fibrous pannus return?
Pannus has led to reoperation in stented xenografts and
mechanical valves in both the aortic and mitral positions,
yet it is not at all a common phenomenon with the free
subcoronary or root replacement allograft aortic valve. I
believe that the stentless xenograft per se, and particularly
the CryoLife-O’Brien model 300, because of the lack of
Dacron backing, should yield a very low incidence of
pannus ingrowth.
Because of the extent of the fibrosis in patient 2, one
wonders (and Luciani, Bertolini, and Mazzucco do sug-
gest) that there may be in this particular patient “the
involvement of biologic reactions in the host.” Neverthe-
less, Luciani, Bertolini, and Mazzucco do inject a note of
caution that pannus ingrowth has occurred in one patient
of a cohort of 40 patients. In my own series of patients,
closely monitored echocardiographically at 6- to 12-month
intervals over the 5 years, I have seen no evidence of
increasing obstruction. In fact, gradients from the left
ventricle to the aorta drop markedly as left ventricular
regression occurs.
In conclusion, I do not accept structural failure as the
correct interpretation in the first patient described by
Luciani, Bertolini, and Mazzucco. I do accept excessive
fibrous tissue overgrowth of causes unknown that have led
to structural device failure and the need for reoperation in
the second patient.
Mark F. O’Brien, FRACS, FRCS
Department of Cardiac Surgery
The Prince Charles Hospital
Brisbane North Region
Rode Rd.
Chermside
Brisbane 4032, Australia
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Reply to the Editor:
We read with interest the thought-provoking comments
of O’Brien on our report of two cases of structural valve
deterioration observed with the O’Brien-Angell stentless
porcine aortic xenograft (Bravo Cardiovascular model
300, CryoLife, Inc., Atlanta, Ga.).1 Several assertions in
O’Brien’s letter, however, deserve a reply.
Regarding the first case of structural deterioration
caused by rupture of the porcine aortic wall support of the
valve, the explanation offered by O’Brien suggests incor-
rect suprannular positioning of the graft. Accordingly,
incomplete incorporation of all the aortic wall support by
the suture line may have promoted rupture of the support
itself. We believe this to be a possible interpretation for
the failure of the device, although unlikely the correct
one. It is, indeed, unclear how one could demonstrate that
incorrect seating of the xenograft would have occurred
based on the iconography presented in the manuscript.
On the contrary, because of space constraints imposed by
the format of the article, additional photographs of the
explanted device could not be provided, which demon-
strate how the profile of the xenograft was perfectly
preserved. This observation is incompatible with the hy-
pothesis of intraannular positioning of the xenograft,
which, as we have observed on other occasions,2 leads to
profound distortion of the xenograft. The morphologic
alterations of xenografts explanted for nonstructural valve
deterioration persist after removal of the bioprosthesis
and are thus readily apparent from the specimen. More
important, as evident from Fig. 1 in our article, rupture of
the support occurred at the level of the right noncoronary
commissural pillar. At this point, incomplete incorpora-
tion of the aortic wall support by the suture line has no
bearing on the final positioning of the xenograft relative to
the anulus. We therefore believe that the diagram (Fig. 1)
proposed by O’Brien, in which a stitch is shown passing
through the nadir of the excised aortic leaflet, adds little
insight to the interpretation of our case. Furthermore, we
are well aware of O’Brien’s outstanding results and the
reported freedom from structural failure of the xenografts
in his series. O’Brien quotes Hvass’s experience with the
O’ Brien-Angell xenograft to support his own excellent
results. However, Hvass did observe two cases of dehis-
cence of the xenograft resulting from slack suture and
rupture of the suture, respectively. Both cases were la-
beled as technical (nonstructural) failure of the device
because the xenografts were reported to be intact and
“refixing the valves on the anulus would have been
sufficient.”3 It is, however, unclear why both xenografts
were replaced with mechanical prostheses. On the con-
trary, several aspects of those two cases are consistent with
structural failure. Indeed, it is difficult to conceive how
rupture of a suture line in the one case may result in
perivalvular leak 10 months after an “initially perfect
result.”3 In addition, one wonders whether the suture may
be slack in the other case because it has not been correctly
tightened or rather because the support has torn, as
occurred in one of our cases.
The question whether connective tissue ingrowth will
recur in our second patient can only be answered in the
short term. Eighteen months after replacement of the
O’Brien-Angell stentless valve with a Hancock II biopros-
thesis (Hancock Extracoporeal Inc., Anaheim, Calif.),
obstruction of the xenograft has not been shown at
echocardiographic assessment and thus significant pannus
formation can be ruled out.
We are grateful to O’Brien for further supplementing
his technical description on how to implant the O’Brien-
Angell stentless xenografts5 with the three diagrams he
has provided. We believe these technical suggestions to be
of premiere importance in avoiding nonstructural failure
of the xenograft resulting from inadequate suprannular
positioning of the valve, which has occurred in our expe-
rience2 as well as in Dr. Hvass’s.3, 4 We remain convinced,
however, that structural failure of this valve, certainly
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caused by pannus ingrowth and possibly caused by rupture
of the support, can occur and is thus worth reporting.
Giovanni Battista Luciani, MD
Paolo Bertolini, MD
Alessandro Mazzucco, MD
Division of Cardiac Surgery
University of Verona
Verona, Italy
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Minimally invasive coronary artery surgery
To the Editor:
We read with great interest the editorial by Reardon
and associates1 regarding minimally invasive coronary
artery surgery. We share their concerns about the safety of
minimally invasive coronary artery bypass, particularly
when the left internal thoracic artery is used to bypass the
left anterior descending artery, our “gold standard.” The
operation with the best track record may have been
converted into an extremely dangerous surgical tool.
Many surgeons attended meetings dealing with mini-
mally invasive coronary artery surgery and returned with
great enthusiasm. From the outset, however, we were very
concerned that small thoracic incisions were not the ideal
approach from the technical and safety standpoints in
patients who could become unstable, regardless of
whether the surgeon had access to the femoral vessels.
We have adopted the surgical exposure described by
Arom, Emery, and Nicoloff.2 We modified their tech-
niques to use a complete sternotomy approach via a small
skin incision, usually 5 inches (12.5 cm) in length. Because
of the skin’s great elasticity, we can perform a complete
median sternotomy using the standard sternal saw. In this
way, we have complete access to the heart via a small skin
incision that is cosmetically appealing.
Through this approach we can mobilize both internal
thoracic arteries and use the radial artery as a free graft to
reach diagnonal branches, the ramus marginalis, or prox-
imal circumflex branches. Because we use cardiopulmo-
nary bypass and the standard antegrade/retrograde car-
dioplegia with the heart still, we can construct perfect
anastomoses. So much has been written about the delete-
rious effects of cardiopulmonary bypass that the safety of
a 5- to 15-minute pump run with cardioplegic arrest has
been forgotten.
We have used this strategy and have not had a single
instance of symptoms or signs of coronary insufficiency
from the operations performed. We wonder whether the
surgeons who have commercial interests in the companies
promoting minimally invasive surgery can claim this com-
pleteness of revascularization and excellence of results.
We congratulate Dr. Reardon and his group for putting a
word of caution to the enthusiasm that minimally invasive
coronary surgery has generated.
Rau´l Garcı´a Rinaldi, MD
Ernesto R. Soltero, MD
Jorge Carballido, MD
Pavı´a Heart Institute
San Juan, Puerto Rico
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Right heart bypass with an extracardiac conduit:
A cautionary tale!
To the Editor:
In this Journal, we1 have recently commented on our
use of total right heart bypass with an extracardiac con-
duit.
In performing this procedure, taking a generous cuff of
the inferior part of the right atrial wall at its junction with
the inferior caval vein, we found it possible to “upsize” the
diameter of the conduit over and above the extant diam-
eter of the caval vein at the level of the diaphragm.
A more recent experience with this surgical approach in
a 4-year-old child with complex cyanotic congenital heart
disease revealed a hidden trap: Rapid accumulation of
ascites in the early postoperative period was accompanied
by a mean gradient of 10 mm Hg between the inferior
caval vein (17 mm Hg) and the conduit (7 mm Hg). The
difference in pressures had been noticed at the time of the
operation but, because of the external appearance of a
wide trumpet-shaped lower anastomosis, the measure-
ments had been discounted as “artifact.” Because of the
increasing ascites, an exploration became necessary when
the gradient across the lower anastomosis was also dem-
onstrated by direct manometry.
On takedown, we observed that a large and prominent
eustachian valve had been caught up in the anastomosis,
producing a partial curtain across the venous pathway.
After excision of the valve and reconstruction of the
anastomosis, the gradient was abolished.
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